Syngenta rejected an unsolicited takeover offer valued at roughly $45 billion from US rival Monsanto, saying the proposed deal undervalued the Swiss agrochemical giant.
In a statement, Basel-based Syngenta said Monsanto had proposed to buy Basel-based Syngenta for 449 Swiss francs per share, with roughly 45% of the payment in cash.
Syngenta said its board of directors unanimously rejected the proposal because it wasn’t in the best interests of the company or its shareholders.
“The offer fundamentally undervalues Syngenta’s prospects,” Syngenta said in its statement Friday. The company added that Monsanto’s proposal underestimated risks involved in executing the deal as well as the regulatory scrutiny it would generate.
Full content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Google and South Carolina Clash Over State Records Demand
May 8, 2024 by
CPI
Telefonica Germany Teams Up with Amazon Web Services to Migrate 5G Customers
May 8, 2024 by
CPI
Federal Judge Grants $7.4 Million Settlement in Pork Price-Fixing Case
May 8, 2024 by
CPI
Wilson Sonsini Bolsters Antitrust and Competition Practice with Key Partner Returns
May 8, 2024 by
CPI
EU to Scrutinize Telecom Italia’s Network Sale to KKR
May 8, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI